01
20 Billion Exosome Particles / 5 mL
Standardized content with high particle density.
EFBA EXONOVA7
Standardized Wharton's Jelly-Derived Exosome Solution
Scientific standardization. Traceable quality. Reliable manufacturing.
Exosome
EXONOVA7 is a premium exosome solution derived from Wharton's Jelly mesenchymal stem cells, standardized through validated manufacturing processes and delivered under cold-chain assurance.
Every vial passes through quality control from production to shipment, prepared with the goal of batch-to-batch consistency.
Standardized Content
02
Wharton's Jelly Derived
Produced from Wharton's Jelly-derived mesenchymal stem cells, ethically obtained after birth.
03
98% Stem Cell Antigen
High-purity, cell-derived content.
04
286 mg Protein Structure
Standardized content supporting the exosomal protein profile.
EFBA EXONOVA7 is manufactured at Vivosel Laboratories, built on rigorous quality standards.
- cGMP-compliant manufacturing processes
- ISO-compliant quality system
- Sterile filling and sterile vials
- Endotoxin-tested product
- Validated manufacturing processes
- Batch-based quality control
- Traceable production records
Certificates of Analysis (CoA), batch test results, and quality control reports can be shared for the products upon request.
Learn More About Our Exosome Solutions
Contact us for detailed information about EFBA EXONOVA7, analysis certificates, and supply terms.